Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 5/20 | 0.47 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | STAT1 | P42224 | 1/20 | 0.43 |
| ▸ | TOP1 | P11387 | 4/20 | 0.43 |
| ▸ | CYCS | P99999 | 3/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759942 | 1.00 | TERT (0.47) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL2535689 | 1.00 | TERT (0.47) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL7150430 | 1.00 | TERT (0.47) | TERTSTAT3STAT1TOP1CYCS | |
| Hydrochloric Acid SCHEMBL8182742 | 0.99 | TERT (0.46) | TERTSTAT3STAT1TOP1CYCS | |
| Hydrochloric Acid SCHEMBL8182065 | 0.99 | TERT (0.46) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL18418 | 0.91 | TERT (0.44) | TERTTOP1CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL7246124 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL4138914 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL30474599 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 | |
| SCHEMBL2375486 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5281616-A | Treatment of human immunodeficiency virus infections | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1994-01-25 | — | — | US | disclosed |
| US-5109016-A | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1992-04-28 | — | — | US | disclosed |
| WO-1989011277-A2 | PORPHYRIN AND PHTHALOCYANINE ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1989-11-30 | — | — | WO | disclosed |